Treatment of acute hepatitis C with interferon alfa-2b

被引:0
|
作者
Muir, AJ [1 ]
Rockey, DC [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 346卷 / 14期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1091 / 1092
页数:2
相关论文
共 50 条
  • [41] Favorable pharmacokinetics of albumin interferon alfa-2b in subjects with chronic hepatitis C
    Fiscella, Michele
    Balan, Vijayan
    Nelson, David
    Bain, Vincent
    Zeuzem, Stefan
    McHutchison, John
    Freimuth, William
    Subramanian, Mani
    Corey, Alfred
    [J]. HEPATOLOGY, 2006, 44 (04) : 613A - 614A
  • [42] COMPARISON OF INTERFERON ALFA-2B IN CIRRHOTIC AND NONCIRRHOTIC PATIENTS WITH HEPATITIS-C
    PODILA, PV
    JENSEN, DM
    GANGER, DR
    ROSENBLATE, HJ
    COY, DL
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A973 - A973
  • [43] Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C
    Wong, JB
    Davis, GL
    Pauker, SG
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 366 - 373
  • [44] Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4.
    Esmat, G
    Abouzied, AM
    Abdel-Aziz, F
    Mohamed, MK
    Abdel-Hamid, M
    El Raziky, MS
    Ismail, SA
    Zalata, KR
    Mikhail, NN
    Fix, A
    Strickland, T
    Sjogren, MH
    [J]. HEPATOLOGY, 2002, 36 (04) : 364A - 364A
  • [45] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111
  • [46] Treatment with pegylated interferon alfa-2b in combination with ribavirin improved health-related quality of life compared with interferon alfa-2b plus ribavirin in chronic hepatitis C.
    Gish, R
    Rzowej, N
    Brooks, L
    Brass, C
    Weng, W
    [J]. HEPATOLOGY, 2002, 36 (04) : 582A - 582A
  • [47] Peg-interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    Attia, M.
    Farouk, D.
    [J]. LIVER INTERNATIONAL, 2006, 26 : 79 - 79
  • [48] Treatment of hepatitis C virus-associated thrombocytopenic purpura with a combination of interferon alfa-2b and ribavirin
    Barel, C
    Bilger, K
    Ninet, J
    Scoazec, JY
    Dumortier, J
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (02) : 200 - 201
  • [49] Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children:: Efficacy, safety, and pharmacokinetics
    González-Peralta, RP
    Kelly, DA
    Haber, B
    Molleston, J
    Murray, KF
    Jonas, MM
    Shelton, M
    Mieli-Vergani, G
    Lurie, Y
    Martin, S
    Lang, T
    Baczkowski, A
    Geffner, M
    Gupta, S
    Laughlin, M
    [J]. HEPATOLOGY, 2005, 42 (05) : 1010 - 1018
  • [50] Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents
    Al Ali, Jaber
    Owayed, Salem
    Al-Qabandi, Wafa'a
    Husain, Khaled
    Hasan, Fuad
    [J]. ANNALS OF HEPATOLOGY, 2010, 9 (02) : 156 - 160